BiondVax Pharmaceuticals Probability of Future Stock Price Finishing Over 1.296
BiondVax Pharmaceuticals' future price is the expected price of BiondVax Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of BiondVax Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Please specify BiondVax Pharmaceuticals' target price for which you would like BiondVax Pharmaceuticals odds to be computed.
BiondVax |
BiondVax Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BiondVax Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BiondVax Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.BiondVax Pharmaceuticals is not yet fully synchronised with the market data | |
BiondVax Pharmaceuticals has some characteristics of a very speculative penny stock | |
BiondVax Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (5.8 M) with profit before overhead, payroll, taxes, and interest of 0. | |
BiondVax Pharmaceuticals currently holds about 14.55 M in cash with (7.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.23. | |
Roughly 20.0% of the company shares are held by company insiders |
BiondVax Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BiondVax Stock often depends not only on the future outlook of the current and potential BiondVax Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BiondVax Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 754.1 B | |
Cash And Short Term Investments | 14.1 M |
BiondVax Pharmaceuticals Technical Analysis
BiondVax Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. BiondVax Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BiondVax Pharmaceuticals. In general, you should focus on analyzing BiondVax Stock price patterns and their correlations with different microeconomic environments and drivers.
BiondVax Pharmaceuticals Predictive Forecast Models
BiondVax Pharmaceuticals' time-series forecasting models is one of many BiondVax Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BiondVax Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about BiondVax Pharmaceuticals
Checking the ongoing alerts about BiondVax Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BiondVax Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BiondVax Pharmaceuticals is not yet fully synchronised with the market data | |
BiondVax Pharmaceuticals has some characteristics of a very speculative penny stock | |
BiondVax Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (5.8 M) with profit before overhead, payroll, taxes, and interest of 0. | |
BiondVax Pharmaceuticals currently holds about 14.55 M in cash with (7.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.23. | |
Roughly 20.0% of the company shares are held by company insiders |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in BiondVax Stock
If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |